Response to botulinum toxin F in seronegative botulinum toxin A-resistant patients
Identifieur interne :
003414 ( PascalFrancis/Corpus );
précédent :
003413;
suivant :
003415
Response to botulinum toxin F in seronegative botulinum toxin A-resistant patients
Auteurs : P. E. Greene ;
S. FahnSource :
-
Movement disorders [ 0885-3185 ] ; 1996.
RBID : Pascal:96-0177085
Descripteurs français
English descriptors
Notice en format standard (ISO 2709)
Pour connaître la documentation sur le format Inist Standard.
pA |
A01 | 01 | 1 | | @0 0885-3185 |
---|
A03 | | 1 | | @0 Mov. disord. |
---|
A05 | | | | @2 11 |
---|
A06 | | | | @2 2 |
---|
A08 | 01 | 1 | ENG | @1 Response to botulinum toxin F in seronegative botulinum toxin A-resistant patients |
---|
A11 | 01 | 1 | | @1 GREENE (P. E.) |
---|
A11 | 02 | 1 | | @1 FAHN (S.) |
---|
A14 | 01 | | | @1 Dystonia Clinical Research Center, Neurological Institute, Columbia-Presbyterian Medical Center @2 New York, New York @3 USA @Z 1 aut. @Z 2 aut. |
---|
A20 | | | | @1 181-184 |
---|
A21 | | | | @1 1996 |
---|
A23 | 01 | | | @0 ENG |
---|
A43 | 01 | | | @1 INIST @2 20953 @5 354000053271850100 |
---|
A44 | | | | @0 0000 |
---|
A45 | | | | @0 9 ref. |
---|
A47 | 01 | 1 | | @0 96-0177085 |
---|
A60 | | | | @1 P |
---|
A61 | | | | @0 A |
---|
A64 | 01 | 1 | | @0 Movement disorders |
---|
A66 | 01 | | | @0 USA |
---|
C02 | 01 | X | | @0 002B02C |
---|
C03 | 01 | X | FRE | @0 Dystonie @5 01 |
---|
C03 | 01 | X | ENG | @0 Dystonia @5 01 |
---|
C03 | 01 | X | SPA | @0 Distonía @5 01 |
---|
C03 | 02 | X | FRE | @0 Toxine @5 04 |
---|
C03 | 02 | X | ENG | @0 Toxin @5 04 |
---|
C03 | 02 | X | SPA | @0 Toxina @5 04 |
---|
C03 | 03 | X | FRE | @0 Clostridium botulinum @2 NS @5 05 |
---|
C03 | 03 | X | ENG | @0 Clostridium botulinum @2 NS @5 05 |
---|
C03 | 03 | X | SPA | @0 Clostridium botulinum @2 NS @5 05 |
---|
C03 | 04 | X | FRE | @0 Chimiothérapie @5 16 |
---|
C03 | 04 | X | ENG | @0 Chemotherapy @5 16 |
---|
C03 | 04 | X | SPA | @0 Quimioterapia @5 16 |
---|
C03 | 05 | X | FRE | @0 Traitement @5 17 |
---|
C03 | 05 | X | ENG | @0 Treatment @5 17 |
---|
C03 | 05 | X | GER | @0 Aufbereiten @5 17 |
---|
C03 | 05 | X | SPA | @0 Tratamiento @5 17 |
---|
C03 | 06 | X | FRE | @0 Homme @5 20 |
---|
C03 | 06 | X | ENG | @0 Human @5 20 |
---|
C03 | 06 | X | SPA | @0 Hombre @5 20 |
---|
C03 | 07 | X | FRE | @0 Résistance traitement @5 23 |
---|
C03 | 07 | X | ENG | @0 Negative therapeutic reaction @5 23 |
---|
C03 | 07 | X | SPA | @0 Resistencia al tratamiento terapeútico @5 23 |
---|
C07 | 01 | X | FRE | @0 Clostridiaceae @2 NS |
---|
C07 | 01 | X | ENG | @0 Clostridiaceae @2 NS |
---|
C07 | 01 | X | SPA | @0 Clostridiaceae @2 NS |
---|
C07 | 02 | X | FRE | @0 Clostridiales @2 NS |
---|
C07 | 02 | X | ENG | @0 Clostridiales @2 NS |
---|
C07 | 02 | X | SPA | @0 Clostridiales @2 NS |
---|
C07 | 03 | X | FRE | @0 Bactérie |
---|
C07 | 03 | X | ENG | @0 Bacteria |
---|
C07 | 03 | X | SPA | @0 Bacteria |
---|
C07 | 04 | X | FRE | @0 Muscle strié pathologie @5 37 |
---|
C07 | 04 | X | ENG | @0 Striated muscle disease @5 37 |
---|
C07 | 04 | X | SPA | @0 Músculo estriado patología @5 37 |
---|
C07 | 05 | X | FRE | @0 Système nerveux pathologie @5 38 |
---|
C07 | 05 | X | ENG | @0 Nervous system diseases @5 38 |
---|
C07 | 05 | X | SPA | @0 Sistema nervioso patología @5 38 |
---|
C07 | 06 | X | FRE | @0 Trouble neurologique @5 39 |
---|
C07 | 06 | X | ENG | @0 Neurological disorder @5 39 |
---|
C07 | 06 | X | SPA | @0 Trastorno neurológico @5 39 |
---|
C07 | 07 | X | FRE | @0 Mouvement involontaire @5 40 |
---|
C07 | 07 | X | ENG | @0 Involuntary movement @5 40 |
---|
C07 | 07 | X | SPA | @0 Movimiento involuntario @5 40 |
---|
C07 | 08 | X | FRE | @0 Extrapyramidal syndrome @5 41 |
---|
C07 | 08 | X | ENG | @0 Extrapyramidal syndrome @5 41 |
---|
C07 | 08 | X | SPA | @0 Extrapiramidal síndrome @5 41 |
---|
N21 | | | | @1 113 |
---|
|
Format Inist (serveur)
NO : | PASCAL 96-0177085 INIST |
ET : | Response to botulinum toxin F in seronegative botulinum toxin A-resistant patients |
AU : | GREENE (P. E.); FAHN (S.) |
AF : | Dystonia Clinical Research Center, Neurological Institute, Columbia-Presbyterian Medical Center/New York, New York/Etats-Unis (1 aut., 2 aut.) |
DT : | Publication en série; Niveau analytique |
SO : | Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 1996; Vol. 11; No. 2; Pp. 181-184; Bibl. 9 ref. |
LA : | Anglais |
CC : | 002B02C |
FD : | Dystonie; Toxine; Clostridium botulinum; Chimiothérapie; Traitement; Homme; Résistance traitement |
FG : | Clostridiaceae; Clostridiales; Bactérie; Muscle strié pathologie; Système nerveux pathologie; Trouble neurologique; Mouvement involontaire; Extrapyramidal syndrome |
ED : | Dystonia; Toxin; Clostridium botulinum; Chemotherapy; Treatment; Human; Negative therapeutic reaction |
EG : | Clostridiaceae; Clostridiales; Bacteria; Striated muscle disease; Nervous system diseases; Neurological disorder; Involuntary movement; Extrapyramidal syndrome |
GD : | Aufbereiten |
SD : | Distonía; Toxina; Clostridium botulinum; Quimioterapia; Tratamiento; Hombre; Resistencia al tratamiento terapeútico |
LO : | INIST-20953.354000053271850100 |
ID : | 96-0177085 |
Links to Exploration step
Pascal:96-0177085
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Response to botulinum toxin F in seronegative botulinum toxin A-resistant patients</title>
<author><name sortKey="Greene, P E" sort="Greene, P E" uniqKey="Greene P" first="P. E." last="Greene">P. E. Greene</name>
<affiliation><inist:fA14 i1="01"><s1>Dystonia Clinical Research Center, Neurological Institute, Columbia-Presbyterian Medical Center</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Fahn, S" sort="Fahn, S" uniqKey="Fahn S" first="S." last="Fahn">S. Fahn</name>
<affiliation><inist:fA14 i1="01"><s1>Dystonia Clinical Research Center, Neurological Institute, Columbia-Presbyterian Medical Center</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">96-0177085</idno>
<date when="1996">1996</date>
<idno type="stanalyst">PASCAL 96-0177085 INIST</idno>
<idno type="RBID">Pascal:96-0177085</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">003414</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Response to botulinum toxin F in seronegative botulinum toxin A-resistant patients</title>
<author><name sortKey="Greene, P E" sort="Greene, P E" uniqKey="Greene P" first="P. E." last="Greene">P. E. Greene</name>
<affiliation><inist:fA14 i1="01"><s1>Dystonia Clinical Research Center, Neurological Institute, Columbia-Presbyterian Medical Center</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Fahn, S" sort="Fahn, S" uniqKey="Fahn S" first="S." last="Fahn">S. Fahn</name>
<affiliation><inist:fA14 i1="01"><s1>Dystonia Clinical Research Center, Neurological Institute, Columbia-Presbyterian Medical Center</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="1996">1996</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Chemotherapy</term>
<term>Clostridium botulinum</term>
<term>Dystonia</term>
<term>Human</term>
<term>Negative therapeutic reaction</term>
<term>Toxin</term>
<term>Treatment</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Dystonie</term>
<term>Toxine</term>
<term>Clostridium botulinum</term>
<term>Chimiothérapie</term>
<term>Traitement</term>
<term>Homme</term>
<term>Résistance traitement</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01>
<fA03 i2="1"><s0>Mov. disord.</s0>
</fA03>
<fA08 i1="01" i2="1" l="ENG"><s1>Response to botulinum toxin F in seronegative botulinum toxin A-resistant patients</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>GREENE (P. E.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>FAHN (S.)</s1>
</fA11>
<fA14 i1="01"><s1>Dystonia Clinical Research Center, Neurological Institute, Columbia-Presbyterian Medical Center</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</fA14>
<fA20><s1>181-184</s1>
</fA20>
<fA21><s1>1996</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000053271850100</s5>
</fA43>
<fA44><s0>0000</s0>
</fA44>
<fA45><s0>9 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>96-0177085</s0>
</fA47>
<fA64 i1="01" i2="1"><s0>Movement disorders</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC02 i1="01" i2="X"><s0>002B02C</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Dystonie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Dystonia</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Distonía</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Toxine</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Toxin</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Toxina</s0>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Clostridium botulinum</s0>
<s2>NS</s2>
<s5>05</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Clostridium botulinum</s0>
<s2>NS</s2>
<s5>05</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Clostridium botulinum</s0>
<s2>NS</s2>
<s5>05</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Chimiothérapie</s0>
<s5>16</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Chemotherapy</s0>
<s5>16</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Quimioterapia</s0>
<s5>16</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Traitement</s0>
<s5>17</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Treatment</s0>
<s5>17</s5>
</fC03>
<fC03 i1="05" i2="X" l="GER"><s0>Aufbereiten</s0>
<s5>17</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Tratamiento</s0>
<s5>17</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Homme</s0>
<s5>20</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Human</s0>
<s5>20</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Hombre</s0>
<s5>20</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Résistance traitement</s0>
<s5>23</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Negative therapeutic reaction</s0>
<s5>23</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Resistencia al tratamiento terapeútico</s0>
<s5>23</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Clostridiaceae</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Clostridiaceae</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Clostridiaceae</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Clostridiales</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Clostridiales</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Clostridiales</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Bactérie</s0>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Bacteria</s0>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Bacteria</s0>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Muscle strié pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Striated muscle disease</s0>
<s5>37</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Músculo estriado patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
<s5>38</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>38</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>38</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Trouble neurologique</s0>
<s5>39</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Neurological disorder</s0>
<s5>39</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Trastorno neurológico</s0>
<s5>39</s5>
</fC07>
<fC07 i1="07" i2="X" l="FRE"><s0>Mouvement involontaire</s0>
<s5>40</s5>
</fC07>
<fC07 i1="07" i2="X" l="ENG"><s0>Involuntary movement</s0>
<s5>40</s5>
</fC07>
<fC07 i1="07" i2="X" l="SPA"><s0>Movimiento involuntario</s0>
<s5>40</s5>
</fC07>
<fC07 i1="08" i2="X" l="FRE"><s0>Extrapyramidal syndrome</s0>
<s5>41</s5>
</fC07>
<fC07 i1="08" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>41</s5>
</fC07>
<fC07 i1="08" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>41</s5>
</fC07>
<fN21><s1>113</s1>
</fN21>
</pA>
</standard>
<server><NO>PASCAL 96-0177085 INIST</NO>
<ET>Response to botulinum toxin F in seronegative botulinum toxin A-resistant patients</ET>
<AU>GREENE (P. E.); FAHN (S.)</AU>
<AF>Dystonia Clinical Research Center, Neurological Institute, Columbia-Presbyterian Medical Center/New York, New York/Etats-Unis (1 aut., 2 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 1996; Vol. 11; No. 2; Pp. 181-184; Bibl. 9 ref.</SO>
<LA>Anglais</LA>
<CC>002B02C</CC>
<FD>Dystonie; Toxine; Clostridium botulinum; Chimiothérapie; Traitement; Homme; Résistance traitement</FD>
<FG>Clostridiaceae; Clostridiales; Bactérie; Muscle strié pathologie; Système nerveux pathologie; Trouble neurologique; Mouvement involontaire; Extrapyramidal syndrome</FG>
<ED>Dystonia; Toxin; Clostridium botulinum; Chemotherapy; Treatment; Human; Negative therapeutic reaction</ED>
<EG>Clostridiaceae; Clostridiales; Bacteria; Striated muscle disease; Nervous system diseases; Neurological disorder; Involuntary movement; Extrapyramidal syndrome</EG>
<GD>Aufbereiten</GD>
<SD>Distonía; Toxina; Clostridium botulinum; Quimioterapia; Tratamiento; Hombre; Resistencia al tratamiento terapeútico</SD>
<LO>INIST-20953.354000053271850100</LO>
<ID>96-0177085</ID>
</server>
</inist>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003414 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 003414 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= PascalFrancis
|étape= Corpus
|type= RBID
|clé= Pascal:96-0177085
|texte= Response to botulinum toxin F in seronegative botulinum toxin A-resistant patients
}}
| This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024 | |